drugset / Trial / NCT00783354

A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)

NCT00783354 ↗

Phase 4 Completed 129 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This double-blind pilot study was conducted to establish the best way of using desloratadine treatment to protect quality of life of chronic idiopathic urticaria (CIU) patients, after an initial 4-weeks of daily treatment: prolonging systematic daily treatment or as needed (PRN; in the case of symptoms).

Timeline

Start
2003-04-01
Primary completion
2004-02-01
Completion
2004-04-01

Outcome

Met primary endpoint

paper At 4 and 8 weeks after randomization, subjects taking continuous DL showed statistically significant improvements in VQ-Dermato Global Index score (P = 0.001 and P = 0.016, respectively) PMID 19133920 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Desloratadine Small molecule 5 mg —